Products
APTIOM® (eslicarbazepine acetate) is indicated as:
- Monotherapy in the management of partial-onset seizures in adult patients with epilepsy. All patients who participated in the monotherapy trial were newly or recently diagnosed with epilepsy.
- Adjunctive therapy in the management of adults, and children above 6 years of age, with partial-onset seizures who are not satisfactorily controlled with conventional therapy.
![CLASTEON® (clodronate disodium) Logo](../assets/img/logos/logo_clasteon.png)
CLASTEON® (clodronate disodium) is indicated:
- as an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors.
- for the management of hypercalcemia of malignancy.
![CTP® (citalopram hydrobromide) Logo](../assets/img/logos/logo-ctp.png)
CTP® (citalopram hydrobromide) is indicated for the symptomatic relief of depressive illness.
![CUBICIN® (daptomycin for injection) Logo](../assets/img/logos/logo-cubicin.png)
CUBICIN® (daptomycin for injection) is indicated for the following infections in adults:
- Complicated skin and skin structure infections (cSSSI) caused by susceptible strains of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillinresistant strains), Streptococcus pyogenes and Streptococcus agalactiae.
- Staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided Staphylococcus aureus infective endocarditis (native valve) caused by methicillin-susceptible and methicillin-resistant strains.
![LATUDA® lurasidone HCI tablets Logo.](../assets/img/logos/latuda-logo.jpg)
LATUDA® (lurasidone HCl) is indicated:
- for the management of the manifestations of schizophrenia.
- as monotherapy or as adjunctive therapy with lithium or valproate for the acute management of depressive episodes associated with bipolar I disorder.
![LUNESTA® (eszopiclone) tablets Logo](../assets/img/logos/lunesta.jpg)
LUNESTA® (eszopiclone) tablets is indicated for the treatment of insomnia and has been shown to decrease sleep latency and improve sleep maintenance.
Download LUNESTA® Product Monograph PDF.
For more information, please visit: www.lunesta.ca
ORGOVYX® (relugolix tablets, 120 mg) is indicated for the treatment of adult patients with advanced prostate cancer
![TROSEC (trospium chloride) Logo](../assets/img/logos/trosec-logo.png)
TROSEC® (trospium chloride) is indicated for the treatment of overactive bladder with symptoms of urge or mixed urinary incontinence, urgency, and urinary frequency.